Pharmacology, Toxicology and Pharmaceutical Science
Tracer
100%
Fluorine 18
79%
Radiopharmaceutical Agent
54%
Neoplasm
51%
Carbon 11
42%
Receptor
40%
Beta Adrenergic Receptor
38%
P-Glycoprotein
35%
Radioligand
34%
Blood-Brain Barrier
23%
Malignant Neoplasm
20%
Adenosine
19%
Biodistribution
16%
Cutamesine
16%
Prostate Cancer
15%
Disease
14%
Amino Acid
13%
Pet Animal
11%
Inflammation
11%
Bombesin
11%
Gastrin Releasing Peptide Receptor
11%
Sigma 1 Opiate Receptor
10%
Mouse
9%
Methionine C 11
9%
Pharmacokinetics
9%
Sigma Receptor Ligand
9%
Beta Adrenergic Receptor Blocking Agent
9%
Wistar Rat
9%
Choline C 11
9%
Sigma Opiate Receptor
9%
Volume of Distribution
8%
Verapamil
8%
Beta Glucuronidase
8%
Arginase
8%
Preladenant
8%
Receptor Agonist
7%
Atorvastatin
7%
Effusion
6%
DOPA
6%
Propranolol
6%
Beta 1 Adrenergic Receptor
6%
2 Propanol
6%
Beta 2 Adrenergic Receptor
6%
Fluorodeoxyglucose F 18
5%
4 (3 Tert Butylamino 2 Hydroxypropoxy) 2 Benzimidazolone
5%
Choline
5%
Technetium 99m
5%
Guanosine Phosphate
5%
Drug Development
5%
Pindolol
5%
Medicine and Dentistry
Positron Emission Tomography
56%
Radioactive Tracer
43%
Positron Emission Tomography
41%
Neoplasm
29%
Fluorine-18
21%
Receptor
14%
Radiopharmaceutical Agent
12%
Choline C 11
12%
In Vitro
11%
Prostate Cancer
9%
Thymidine
9%
Malignant Neoplasm
9%
Adenosine
7%
Oncology
6%
Carbon 11
6%
Molecular Imaging
6%
Choline
5%
Cutamesine
5%
Sigma 1 Opiate Receptor
5%
T Cell
5%
Preladenant
5%
Beta Glucuronidase
5%
Ex Vivo
5%
Keyphrases
F-18
33%
Positron Emission Tomography
31%
C-11
23%
P-glycoprotein Activity
17%
β-adrenoceptor
14%
Blood-brain Barrier
14%
P-glycoprotein (P-gp)
14%
Positron Emission Tomography Tracers
10%
Radioligand
10%
Radiopharmaceuticals
10%
Verapamil
9%
Tumor
9%
Fluoro
8%
In Vivo Imaging
7%
Nonhuman Primate
7%
SA4503
6%
Volume of Distribution
6%
MicroPET
6%
PET Imaging
6%
CD103
6%
Compartmental Model
6%
Rodents
5%
PET Study
5%
Radiochemistry
5%
Tissue Compartments
5%
Lung
5%
Rat Brain
5%
Tyrosine
5%
PET Tracer
5%
Radiopharmacy
5%
Adenosine A1 Receptor
5%
Receptor Occupancy
5%